TOVX - Theriva Biologics, Inc.
0.1808
-0.004 -1.991%
Share volume: 1,557,224
Last Updated: 03-06-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.26%
PREVIOUS CLOSE
CHG
CHG%
$0.18
0.00
-0.02%
View ratios
| Fiscal Date | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | |
| Report Date | 11-12-2024 | 03-06-2025 | 05-14-2025 | 08-11-2025 | 11-12-2025 | |
| Cash flow financing | 3.716 M | 7.000 K | 3.072 M | 6.811 M | -148.000 K | |
| Other financing cash flows | 0.000 | 0.000 | 1.727 M | 75.000 K | -459.000 K | |
| Cash flow | 0.000 | 0.000 | -1.684 M | 2.083 M | -4.486 M | |
| Net income | -7.726 M | -4.446 M | -4.324 M | -13.058 M | -4.361 M | |
| Depreciation | 33.000 K | 27.000 K | 26.000 K | 27.000 K | 28.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 0.000 | 0.000 | 0.000 | -16.000 K | -19.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 19.000 K | |
| Cash Change | -180.000 K | -4.807 M | -1.591 M | 2.052 M | -4.592 M |